These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19897610)

  • 21. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
    Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G
    Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor.
    Veyrat-Durebex C; Pomerleau L; Langlois D; Gaudreau P
    J Cell Physiol; 2005 May; 203(2):335-44. PubMed ID: 15499571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding.
    Alba M; Salvatori R
    J Endocrinol; 2005 Sep; 186(3):515-21. PubMed ID: 16135671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction.
    Wang CY; Wang Y; Kwok AH; Leung FC
    J Endocrinol; 2007 Dec; 195(3):525-36. PubMed ID: 18000314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of 5'-promoter activity of the rat growth hormone and growth hormone-releasing hormone receptor genes in the MtT/S and MtT/E cells.
    Nogami H; Hiraoka Y; Inoue K; Aiso S; Hisano S
    Neuroendocrinology; 2006; 84(1):31-41. PubMed ID: 17090972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
    Siejka A; Schally AV; Block NL; Barabutis N
    Prostate; 2010 Jul; 70(10):1087-93. PubMed ID: 20232355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132.
    Volakaki AA; Lafkas D; Kassi E; Schally AV; Papavassiliou AG; Kiaris H
    J Mol Endocrinol; 2008 Nov; 41(5):389-92. PubMed ID: 18765563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
    Pozsgai E; Schally AV; Zarandi M; Varga JL; Vidaurre I; Bellyei S
    Int J Cancer; 2010 Nov; 127(10):2313-22. PubMed ID: 20162575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
    Siriwardana G; Bradford A; Coy D; Zeitler P
    Mol Endocrinol; 2006 Sep; 20(9):2010-9. PubMed ID: 16613992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody.
    Schulz S; Röcken C; Schulz S
    Eur J Cancer; 2006 Sep; 42(14):2390-6. PubMed ID: 16904887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
    Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
    Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive signal bias mediated by the human GHRHR splice variant 1.
    Cong Z; Zhou F; Zhang C; Zou X; Zhang H; Wang Y; Zhou Q; Cai X; Liu Q; Li J; Shao L; Mao C; Wang X; Wu J; Xia T; Zhao LH; Jiang H; Zhang Y; Xu HE; Cheng X; Yang D; Wang MW
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34599099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding.
    McElvaine AT; Mayo KE
    Endocrinology; 2006 Apr; 147(4):1884-94. PubMed ID: 16423869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
    Seitz S; Hohla F; Schally AV; Moder A; Engel JB; Horn F; Varga J; Zarandi M; Ortmann O; Köster F; Buchholz S
    Oncol Rep; 2008 Nov; 20(5):1289-94. PubMed ID: 18949435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
    Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.